IR Meeting for 2025 Q4 Results and R&D Progress
-
IR for 2025 Q4 results and R&D progress on Feb 9, 2026 at 14:00 via Zoom conference call
-
Participants: institutional investors, analysts, journalists, individual investors
-
IR materials to be posted on company website
KOSPI Filing Information
-
-
Corporate Briefing (IR) Holding (Notice Disclosure)
-
Company: BUKWANG PHARMACEUTICAL IND (003000)
-
Submission: BUKWANG PHARMACEUTICAL IND CO.,LTD
-
Under KRX KOSPI Market Division
-
-
Shares: 98,664,671
-
Price: 4,015 KRW
-
Market Cap: 396.1 B KRW